Brief: CK Life Sciences Intl Unit Enters Licensing Deal For COVID-19 Detection Kit
March 27 (Reuters) - CK Life Sciences Intl (Holdings) Inc
0775.HK :
* UNIT ENTERED LICENSING AGREEMENT WITH UNIT OF SINGAPORE'S
AGENCY
FOR SCIENCE, TECHNOLOGY AND RESEARCH
* AGREEMENT TO MAKE, DISTRIBUTE, & SELL SARS-COV-2 RT-PCR
DIAGNOSTIC TEST KIT FOR COVID-19 DETECTION IN HK & WORLDWIDE
* APPLICATION MADE TO HK STOCK EXCHANGE FOR RESUMPTION OF
TRADING
IN SHARES FROM 30 MARCH
Source text for Eikon: ID:nHKS40G0FT
Further company coverage: 0775.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CK Life Sciences Intl (Holdings)
See all newsCK Life Sciences H1 loss narrows on lower R&D costs
Brief: CK Life Sciences Intl Announces Resignation Of Lance Richard Lee Yuen As Executive Director, CEO
Brief: CK Life Sciences Intl Logs FY Loss Attributable HK$186.8 Mln
CK Life Sciences rises most in 4 months on advancing cancer vaccine development
Brief: CK Life Sciences Intl Establishes Sequencio Therapeutics For Cancer Vaccine Development